Blood components : Are they drugs or special medicines?
Copyright © 2016. Published by Elsevier SAS..
Blood transfusion and plasma derived-drugs significantly differ from other medicines in that their availability strictly depends on blood and plasma collected from healthy donors. Blood collection must comply with a double objective: to maintain donor heath safety, and to avoid any transmitted infections in recipients. This raises several ethical concerns that appear to be different from usual ethical and deontological issues linked to other pharmaceutical and industrial processes. The main concern is the non-commercialization of the human body. Words and concept are of major importance in this context. This short review aims at presenting the main issues relevant to those questions with respect to the various stakeholders.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine - 23(2016), 3 vom: 01. Sept., Seite 127-31 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
Les produits sanguins thérapeutiques : des médicaments ou des produits de santé à part ? |
|---|
| Beteiligte Personen: |
Garraud, O [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 30.10.2017 Date Revised 30.10.2017 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.tracli.2016.06.001 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM262495759 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM262495759 | ||
| 003 | DE-627 | ||
| 005 | 20231224201857.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2016 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1016/j.tracli.2016.06.001 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0875.xml |
| 035 | |a (DE-627)NLM262495759 | ||
| 035 | |a (NLM)27424282 | ||
| 035 | |a (PII)S1246-7820(16)30019-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Garraud, O |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Blood components |b Are they drugs or special medicines? |
| 246 | 3 | 3 | |a Les produits sanguins thérapeutiques : des médicaments ou des produits de santé à part ? |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.10.2017 | ||
| 500 | |a Date Revised 30.10.2017 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2016. Published by Elsevier SAS. | ||
| 520 | |a Blood transfusion and plasma derived-drugs significantly differ from other medicines in that their availability strictly depends on blood and plasma collected from healthy donors. Blood collection must comply with a double objective: to maintain donor heath safety, and to avoid any transmitted infections in recipients. This raises several ethical concerns that appear to be different from usual ethical and deontological issues linked to other pharmaceutical and industrial processes. The main concern is the non-commercialization of the human body. Words and concept are of major importance in this context. This short review aims at presenting the main issues relevant to those questions with respect to the various stakeholders | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Altruism | |
| 650 | 4 | |a Altruisme | |
| 650 | 4 | |a Blood donation | |
| 650 | 4 | |a Blood transfusion | |
| 650 | 4 | |a Don de sang | |
| 650 | 4 | |a Ethics | |
| 650 | 4 | |a Médicaments dérivés du plasma | |
| 650 | 4 | |a Non-profit | |
| 650 | 4 | |a Not-for-profit | |
| 650 | 4 | |a Plasma derived-drugs | |
| 650 | 4 | |a Transfusion sanguine | |
| 650 | 4 | |a Éthique | |
| 650 | 7 | |a Biological Factors |2 NLM | |
| 650 | 7 | |a Biological Products |2 NLM | |
| 650 | 7 | |a Blood Proteins |2 NLM | |
| 650 | 7 | |a Pharmaceutical Preparations |2 NLM | |
| 700 | 1 | |a Tissot, J-D |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine |d 1994 |g 23(2016), 3 vom: 01. Sept., Seite 127-31 |w (DE-627)NLM074905449 |x 1953-8022 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2016 |g number:3 |g day:01 |g month:09 |g pages:127-31 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.tracli.2016.06.001 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2016 |e 3 |b 01 |c 09 |h 127-31 | ||